Campaign for Personal Prescription Importation

What Campaign for Personal Prescription Importation does

The Campaign for Personal Prescription Importation (CPPI) is a U.S. nonprofit patient advocacy organization headquartered in Hillsborough, New Jersey, that campaigns for Americans' legal right to import prescription medications for personal use from licensed Canadian pharmacies. Founded more than two decades ago, CPPI represents a stated membership of over 135,000 U.S. residents — predominantly uninsured, underinsured, senior, and chronically ill patients — who rely on personal importation to afford brand-name maintenance medications for conditions such as diabetes, hypertension, heart disease, asthma, and COPD. The organization does not sell medications and does not operate a software platform; its "products" are advocacy resources, an educational website (www.personalimportation.org), a Find-a-Pharmacy directory pointing to CIPA-certified Canadian pharmacies, a savings calculator, member testimonials, and an action platform for contacting Congress.

CPPI is governed by an Executive Director (Ken Hunter, since January 2025, succeeding Jack Pfeiffer) and a Board, with operations running on 11–50 employees out of a single NJ office. Its core technology stack is minimal — a Wix-hosted website, Constant Contact for email distribution, and Stripe/PayPal for payment processing — reflecting that the organization's value is delivered through grassroots advocacy and policy work rather than through a digital product. CPPI publicly endorses and lobbies for federal importation legislation, including S. 4918 (Klobuchar/Grassley, 2024), H.R. 8848 (Schakowsky, 2024), and H.R. 3162 (Schakowsky/Sanders, 2025), and partners with the Canadian International Pharmacy Association (CIPA) as its safety-credentialing reference point.

Revenue is generated entirely through optional member donations and three recurring monthly support tiers (Bronze $10, Silver $25, Gold $50), with all services provided free of charge. CPPI cites member-survey evidence that importers save an average of $4,920/year (and 52–89% per drug versus U.S. prices), and notes that CIPA-certified pharmacies have maintained a 100% safety record over two decades. The organization's primary commercial risk is policy-driven: the scheduled August 29, 2025 elimination of the $800 de minimis import duty exemption threatens to materially raise the cost of cross-border mail-order medication for its member base.

Name

Campaign for Personal Prescription Importation

Legal name

The Campaign for Personal Prescription Importations, CPPI Inc.

Website

https://personalimportation.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Campaign for Personal Prescription Importation is a U.S. nonprofit advocacy organization that campaigns for Americans' right to import prescription medications from licensed Canadian pharmacies, serving over 135,000 members who rely on personal importation to afford brand-name drugs.

Ownership category

akta.pro rank

Headquarters

HQ city

Hillsborough

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Revenue model

1. Membership Dues and Donations: CPPI operates as a nonprofit organization. It generates revenue through optional membership support tiers ($10, $25, $50/month) and one-time donations. The organization does not sell pharmaceutical products. Revenue supports advocacy operations, policy outreach, and member communications.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Campaign for Personal Prescription Importation (CPPI) is a nonprofit patient advocacy organization that advocates for Americans' right to legally import safe, lower-cost prescription medications from licensed Canadian pharmacies. CPPI does not sell medications; instead it provides free membership enrollment, educational resources on safe importation pathways, a "Find a Pharmacy" tool linking members to CIPA-certified Canadian pharmacies, advocacy tools for contacting Congress, and a platform for member testimonials about cost savings.

Product overview

The Campaign for Personal Prescription Importation (CPPI) is a non-profit advocacy organization that does not offer a technology product in the traditional sense. CPPI's services consist of advocacy resources, educational content about prescription drug importation from Canada, a Find a Pharmacy resource linking Americans to licensed Canadian pharmacies, membership/newsletter enrollment, and a platform for sharing personal testimonials about medication affordability. The organization does not provide a software platform, application, or digital product for sale.

Differentiator

Problem solved

Functional benefit

Products and services

• Free CPPI Membership and Newsletter

Quantifiable outcome

• Americans who import medications save an average of $4,920 per year
• +4 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and minor.

• Sen. Bernie Sanders and Rep. Jan SchakowskycoreGTM or Marketing Partner · 30 May 2025CPPI endorsed the Affordable and Safe Prescription Drug Importation Act of 2025 (H.R. 3162), introduced by Rep. Jan Schakowsky, with Sen. Bernie Sanders as a long-standing champion of the legislation. CPPI actively advocates alongside these legislators to advance importation bills.
• Senators Amy Klobuchar (D-MN) and Chuck Grassley (R-IA)coreGTM or Marketing Partner · 19 September 2024CPPI endorsed the Safe and Affordable Drugs From Canada Act of 2024 (S. 4918) introduced by Senators Klobuchar and Grassley, with co-sponsors including Senators Tammy Baldwin, Sherrod Brown, Angus King, Jeff Merkley, Jeanne Shaheen, and Sheldon Whitehouse. CPPI has partnered with these legislators for over a decade to advance importation legislation.
• Rep. Jan Schakowsky (IL-09)coreGTM or Marketing Partner · 27 June 2024CPPI endorsed the Affordable and Safe Prescription Drug Importation Act of 2024 (H.R. 8848) introduced by Congresswoman Jan Schakowsky. CPPI works with Rep. Schakowsky as a champion for legislation enabling Americans to import affordable medications from Canada.
• Canadian International Pharmacy Association (CIPA)coreStrategic or Co-development PartnerCPPI actively partners with and references CIPA as the certifying body for safe online Canadian pharmacies. CIPA-certified pharmacies have a 100% perfect safety record over more than two decades. CPPI directs members to CIPA-certified pharmacies and promotes CIPA's safety standards and list of approved pharmacies as a core part of its mission to ensure safe importation pathways.
• Constant ContactminorOthersCPPI uses Constant Contact as its mass email processor for distributing newsletters and advocacy communications to its membership base. This is a vendor relationship for email marketing services.
• Stripe and PayPalminorOthersCPPI uses Stripe and PayPal as third-party payment processors for handling member donations and contributions. These are vendor relationships for payment processing services.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Prescription Justice: Advocacy organization specifically promoting personal drug importation and against drug industry practices. Directly comparable to CPPI in advocacy focus and constituency (Americans importing medications), and an explicit ally in importation policy campaigns.
• Public Citizen: Consumer advocacy nonprofit with a Health Research Group that has long campaigned on drug pricing and importation. Shares CPPI's advocacy methodology (legislative campaigns, public education, member mobilization) on overlapping healthcare-cost issues.
• Families USA: National nonpartisan consumer health advocacy organization. Comparable to CPPI as a nonprofit advocacy group driving healthcare consumer policy, though broader in scope across the full healthcare affordability agenda.
• Patients For Affordable Drugs Now: Patient-led advocacy organization focused on lowering prescription drug prices in the U.S. Closely comparable to CPPI in mission and GTM (grassroots advocacy, member testimonials, policy campaigns), though broader in scope than importation specifically.

Emerging players

• GoodRx: Public-traded platform providing prescription price comparison and discount coupons in the U.S. Tackles the same underlying problem CPPI addresses (high U.S. drug prices) via a commercial, marketplace-driven model rather than cross-border importation.
• Rx Savings Solutions: Healthcare technology company that helps employers and consumers find lower prescription drug prices. Addresses an overlapping consumer pain point (drug affordability) through a private-sector, technology-enabled model rather than advocacy.

Broad incumbents

• AARP: Large mass-membership advocacy organization for older Americans with substantial drug-pricing policy work. Overlaps with CPPI's senior-on-fixed-income segment and shares advocacy for lower drug costs, but operates at much greater scale across many policy areas.

Others

• Pharmaceutical Research and Manufacturers of America (PhRMA): Lobbying trade association representing the branded pharmaceutical industry. The principal opposing force against CPPI's importation advocacy, with vastly greater lobbying resources. Comparable as a stakeholder in the same policy debate rather than a like-mission organization.
• Canadian International Pharmacy Association (CIPA): Canadian trade association that certifies legitimate online Canadian pharmacies. A core CPPI partner and the safety-verification backbone for CPPI's pharmacy referrals; comparable as an ecosystem participant but not a competing advocacy organization.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/rximportation
• Facebookfacebook.com/personalimportation
• Instagraminstagram.com/personalimportation
• LinkedInlinkedin.com/company/campaign-for-personal-prescription-importation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Campaign for Personal Prescription Importation